Title:Effect of Herbal Medicine on Insulin Signaling Pathways and Insulin Resistance in Metabolic Dysfunction-associated Fatty Liver Disease: A Review
Volume: 15
Issue: 4
Author(s): A.M.D.S. Karunaratna and S. Ekanayake*
Affiliation:
- Department of Biochemistry, Faculty of Medical Sciences, University of Sri Jayewardenepura, Nugegoda, Sri Lanka
Keywords:
Metabolic dysfunction, fatty liver disease, herbal medicines, insulin resistance, natural products, GLUT, AMPK pathway, PI3K/AKT pathway.
Abstract:
Introduction: Metabolic dysfunction-associated fatty liver disease (MAFLD) is the most
common chronic liver disease progressing towards a substantial global health concern. A multitude
of therapeutic agents are being used to treat MAFLD. The high prevalence and adverse effects of
drugs have increased the global popularity of herbal medicines (HMs) as effective therapeutic agents
to treat MAFLD. Among the causes of pathogenesis, insulin resistance (IR) plays a crucial role in
MAFLD. Hence, the amelioration of IR has emerged as a promising target for potential therapeutic
approaches in MAFLD.
Aim: This study aimed to explore in vitro and in vivo mechanisms that unveil recent advances in
HMs that target the amelioration of IR in MAFLD.
Materials and Methods: Electronic databases, including PubMed and MEDLINE, were used to
search literature for HMs in the management or treatment of NAFLD published up to March, 2023.
The three primary search terms were “MAFLD” “NAFLD” and “HM”. MeSH of NAFLD, such as
(Non-alcoholic fatty liver disease, Non-alcoholic Steatohepatitis) and HM (Medicinal plants, Plant
extracts), and keywords were used to optimize the search strategy.
Results: HMs act on a multitude of molecular pathways that increase insulin sensitization including
upregulation of the secretion and activation of insulin receptor substrate (IRS) proteins, upregulation
of phosphatidylinositol 3-kinase (PI3K)/AKT (also known as PKB or protein kinase B) signaling
pathway, activation of the 5' AMP-activated protein kinase (AMPK) pathway and modulation of
enzymes of glucose homeostasis, regeneration of the pancreatic β-cell mass, modulation of secretion
of adipokines, enhancement of the uptake of glucose into tissues via increased expression of GLUT
in tissues, and upregulation of FGF1/FGF1R signaling pathway.
Conclusion: HMs possess a multitude of potential actions that reduce the IR and improve glucose
homeostasis. Hence, HMs are a promising resource as effective medications for the treatment of
MAFLD.
